Clinical trial
Endophenotype for Alcohol Misuse in Healthy Minority Populations
NCT00256451 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00256451 |
|---|---|
| Title | Endophenotype for Alcohol Misuse in Healthy Minority Populations |
| Official title | Defining an Endophenotype for Alcohol Misuse: A Focus On Minority Populations |
| Acronym | DEFINE |
| Lead sponsor | University of Pennsylvania, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug, Other |
| Interventions | Naltrexone, placebo, alcohol, Sham alcohol |
| Enrollment | 43 |
| Start date | Nov 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Nov 21, 2005 |
| Last update posted | Aug 21, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: